←Back to Expert Scholars
Translational Medicine / 转化医学Advanced Merkel Cell Carcinoma
Shailender Bhatia
MD
🏢University of Washington / Fred Hutch🌐USA
Professor of Medicine
50
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Shailender Bhatia leads Merkel cell carcinoma clinical trials at the University of Washington. He contributed to pivotal avelumab studies establishing anti-PD-L1 therapy in metastatic MCC. His work includes combination immunotherapy strategies for refractory disease.
Share:
🧪Research Fields 研究领域
Merkel cell carcinoma
Avelumab
Immunotherapy trials
Advanced skin cancers
Translational research
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Shailender Bhatia 的研究动态
Follow Shailender Bhatia's research updates
留下邮箱，当我们发布与 Shailender Bhatia（University of Washington / Fred Hutch）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment